PharmaSGP Holding SE
XETRA:PSG

Watchlist Manager
PharmaSGP Holding SE Logo
PharmaSGP Holding SE
XETRA:PSG
Watchlist
Price: 24.6 EUR -0.81% Market Closed
Market Cap: 295.2m EUR
PSG
/
Income Statement
/
Income from Continuing Operations

PharmaSGP Holding SE
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaSGP Holding SE
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
PharmaSGP Holding SE
XETRA:PSG
Income from Continuing Operations
€16.4m
CAGR 3-Years
16%
CAGR 5-Years
2%
CAGR 10-Years
N/A
ATAI Life Sciences NV
NASDAQ:ATAI
Income from Continuing Operations
-$40.3m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Income from Continuing Operations
-€876m
CAGR 3-Years
N/A
CAGR 5-Years
10%
CAGR 10-Years
N/A
Merck KGaA
XETRA:MRK
Income from Continuing Operations
€2.7B
CAGR 3-Years
0%
CAGR 5-Years
19%
CAGR 10-Years
9%
MPH Health Care AG
XETRA:93M1
Income from Continuing Operations
€29.5m
CAGR 3-Years
N/A
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Income from Continuing Operations
€89.3m
CAGR 3-Years
-18%
CAGR 5-Years
4%
CAGR 10-Years
N/A

PharmaSGP Holding SE
Glance View

Market Cap
295m EUR
Industry
Pharmaceuticals

PharmaSGP Holding SE engages in the sale and marketing of non-prescription drugs, chemical-free over-the-counter painkillers, as well as herbal medicines. The company is headquartered in Graefelfing, Bayern. The company went IPO on 2020-06-19. The firm produces and develops non-chemical and over-the-counter drugs and other healthcare products.

PSG Intrinsic Value
41.65 EUR
Undervaluation 41%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is PharmaSGP Holding SE's Income from Continuing Operations?
Income from Continuing Operations
16.4m EUR

Based on the financial report for Dec 31, 2023, PharmaSGP Holding SE's Income from Continuing Operations amounts to 16.4m EUR.

What is PharmaSGP Holding SE's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
2%

Over the last year, the Income from Continuing Operations growth was 37%. The average annual Income from Continuing Operations growth rates for PharmaSGP Holding SE have been 16% over the past three years , 2% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 238,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.